HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Essential thrombocythemia after treatment of non-Hodgkin's lymphoma.

AuthorsJames Farley Rafael Maciel, Maria de Lourdes Chauffaille, Riguel Jun Inaoka, Gisele Wally Braga Colleoni, Mihoko Yamamoto
JournalLeukemia research (Leuk Res) Vol. 31 Issue 11 Pg. 1593-5 (Nov 2007) ISSN: 0145-2126 [Print] England
PMID17324461 (Publication Type: Case Reports, Letter)
Chemical References
  • Vincristine
  • Doxorubicin
  • Cyclophosphamide
  • Prednisolone
Topics
  • Antineoplastic Combined Chemotherapy Protocols (adverse effects, therapeutic use)
  • Cyclophosphamide (adverse effects, therapeutic use)
  • Doxorubicin (adverse effects, therapeutic use)
  • Humans
  • Lymphoma, Non-Hodgkin (drug therapy)
  • Male
  • Middle Aged
  • Prednisolone (adverse effects, therapeutic use)
  • Thrombocythemia, Essential (chemically induced)
  • Vincristine (adverse effects, therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: